Dendrimer mediated targeting of siRNA against polo‐like kinase for the treatment of triple negative breast cancer

A Jain, S Mahira, JP Majoral… - … Research Part A, 2019 - Wiley Online Library
Irresponsiveness of triple negative breast cancer (TNBC) toward conventional therapies has
drawn attention toward siRNA therapeutics. In gene delivery, dendrimers are gaining …
被引用次数：37 相关文章

Dendrimer mediated targeting of siRNA against polo-like kinase for the treatment of triple negative breast cancer.

A Jain, S Mahira, JP Majoral, M Bryszewska… - Journal of Biomedical …, 2019 - europepmc.org
Irresponsiveness of triple negative breast cancer (TNBC) toward conventional therapies has
drawn attention toward siRNA therapeutics. In gene delivery, dendrimers are gaining …

Dendrimer mediated targeting of siRNA against Polo-like kinase for the treatment of triple negative breast cancer

A Jain, S Mahira, JP Majoral, M Bryszewska… - Journal of Biomedical …, 2019 - son.uni.lodz.pl
Irresponsiveness of triple negative breast cancer (TNBC) toward conventional therapies has
drawn attention toward siRNA therapeutics. In gene delivery, dendrimers are gaining …

Dendrimer mediated targeting of siRNA against polo‐like kinase for the treatment of triple negative breast cancer

A Jain, S Mahira, JP Majoral, M Bryszewska… - Journal of Biomedical …, 2019 - hal.science
Irresponsiveness of triple negative breast cancer (TNBC) toward conventional therapies has
drawn attention toward siRNA therapeutics. In gene delivery, dendrimers are gaining …

Dendrimer mediated targeting of siRNA against polo-like kinase for the treatment of triple negative breast cancer

A Jain, S Mahira, JP Majoral… - … research. Part A, 2019 - pubmed.ncbi.nlm.nih.gov
Irresponsiveness of triple negative breast cancer (TNBC) toward conventional therapies has
drawn attention toward siRNA therapeutics. In gene delivery, dendrimers are gaining …